> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Protega Abuse-Deterrent Oxycodone Approved
- URL: https://www.fdaweb.com/protega-abuse-deterrent-oxycodone-approved/
- Published: 2024-10-29T12:00:00.000Z
- Updated: 2026-09-14T14:45:31.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5158077

FDA has approved Protega Pharmaceuticals’ Roxybond (oxycodone hydrochloride), an abuse-deterrent, immediate-release (IR) 10 mg tablet for managing pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. The company says Roxybond is the only abuse-deterrent IR 10 mg oxycodone formulation that is expected to reduce abuse by intranasal and intravenous routes. It is formulated with the company’s SentryBond abuse-deterrent technology that “combines inactive excipients with active pharmaceutical ingredients to make the tablet more difficult to manipulate for misuse and abuse, even if it is subjected to physical manipulation and/or chemical extraction,” it says.